Exclusion of corticosterone from epithelial mineralocorticoid receptors is insufficient for selectivity of aldosterone action: In vivo binding studies

被引:121
作者
Funder, J [1 ]
Myles, K [1 ]
机构
[1] BAKER MED RES INST, MELBOURNE, VIC, AUSTRALIA
关键词
D O I
10.1210/en.137.12.5264
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Adrenalectomized weanling rats injected with [H-3]aldosterone plus excess RU486, with or without a range of doses of nonradioactive aldosterone or corticosterone, show tissue-specific patterns of competition for tracer binding to mineralocorticoid receptors (MR). From detailed dose-response curves, corticosterone in vivo shows approximately 3% the apparent affinity of aldosterone for MR in colon and kidney, approximately 30% for those in the heart, and approximately 300% in the hippocampus. We interpret these data as evidence that 1) relatively low levels of aldosterone cross the blood-brain barrier; and 2) specificity-conferring mechanisms in addition to the exclusion of corticosterone from epithelial MR are required for selective aldosterone action in sodium homeostasis.
引用
收藏
页码:5264 / 5268
页数:5
相关论文
共 29 条
  • [21] MINERALOCORTICOID AND GLUCOCORTICOID RECEPTOR ACTIVITIES DISTINGUISHED BY NONRECEPTOR FACTORS AT A COMPOSITE RESPONSE ELEMENT
    PEARCE, D
    YAMAMOTO, KR
    [J]. SCIENCE, 1993, 259 (5098) : 1161 - 1165
  • [22] RUSVAI E, 1993, J BIOL CHEM, V268, P10717
  • [23] EQUIVALENT AFFINITY OF ALDOSTERONE AND CORTICOSTERONE FOR TYPE-I RECEPTORS IN KIDNEY AND HIPPOCAMPUS - DIRECT BINDING-STUDIES
    SHEPPARD, KE
    FUNDER, JW
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1987, 28 (06) : 737 - 742
  • [24] STEWART PM, 1987, LANCET, V2, P821
  • [25] A MUTATION IN THE HSD11B2 GENE IN A FAMILY WITH APPARENT MINERALOCORTICOID EXCESS
    WILSON, RC
    KROZOWSKI, ZS
    LI, K
    OBEYESEKERE, VR
    RAZZAGHYAZAR, M
    HARBISON, MD
    WEI, JQ
    SHACKLETON, CHL
    FUNDER, JW
    NEW, MI
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (07) : 2263 - 2266
  • [26] SEVERAL HOMOZYGOUS MUTATIONS IN THE GENE FOR 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-2 IN PATIENTS WITH APPARENT MINERALOCORTICOID EXCESS
    WILSON, RC
    HARBISON, MD
    KROZOWSKI, ZS
    FUNDER, JW
    SHACKLETON, CHL
    HANAUSKEABEL, HM
    WEI, JQ
    HERTECANT, J
    MORAN, A
    NEIBERGER, RE
    BALFE, JW
    FATTAH, A
    DANEMAN, D
    LICHOLAI, T
    NEW, MI
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (11) : 3145 - 3150
  • [27] DETERMINANTS OF CARDIAC FIBROSIS IN EXPERIMENTAL HYPERMINERALOCORTICOID STATES
    YOUNG, M
    HEAD, G
    FUNDER, J
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1995, 269 (04): : E657 - E662
  • [28] MINERALOCORTICOIDS, HYPERTENSION, AND CARDIAC FIBROSIS
    YOUNG, M
    FULLERTON, M
    DILLEY, R
    FUNDER, J
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (06) : 2578 - 2583
  • [29] YOUNG MJ, IN PRESS AM J PHYSL